CAMPATH (alemtuzumab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAMPATH (alemtuzumab), covering 2015-03-26 to 2015-03-26. Get the full timeline:
Most recent: Clinical Trial Update: Rituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHL [Phase 1, Phase 2]